Ahmedabad: Pharma major, Zydus Cadila today informed that the company has received the final approval from the US drug regulator to market Telmisartan tablets of 20mg, 40mg and 80mg in the US market.
The estimated sales in 2014 for Telmisartan tablets, which fall in the anti-hypertensive segment is $233.3 million, as per IMS.
